ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast CancerKeiko Fukushima(Zenyaku Kogyo (Japan))Cancer Research CommunicationsFebruary 1, 202610.1158/2767-9764.crc-25-0119Cited by 0SaveCiteExport RISWatch citationsRelated PapersNovel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface|Oncotarget|2024|1